WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001006446) AUTOMATED METHOD FOR IMAGE ANALYSIS OF RESIDUAL PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/006446    International Application No.:    PCT/US2000/018517
Publication Date: 25.01.2001 International Filing Date: 07.07.2000
Chapter 2 Demand Filed:    08.02.2001    
IPC:
G06T 7/60 (2006.01)
Applicants: CHROMAVISION MEDICAL SYSTEMS, INC. [US/US]; 33171 Paseo Cerveza, San Juan Capistrano, CA 92675 (US) (For All Designated States Except US).
HAYS, Presley [US/US]; (US) (For US Only).
PERI, Michele [US/US]; (US) (For US Only).
HARRINGTON, Douglas [US/US]; (US) (For US Only)
Inventors: HAYS, Presley; (US).
PERI, Michele; (US).
HARRINGTON, Douglas; (US)
Agent: HARRIS, Scott, C.; Fish & Richardson P.C., Suite 500, 4350 La Jolla Village Drive, La Jolla, CA 92122 (US)
Priority Data:
60/143,181 09.07.1999 US
Title (EN) AUTOMATED METHOD FOR IMAGE ANALYSIS OF RESIDUAL PROTEIN
(FR) PROCEDE AUTOMATISE D'ANALYSE D'IMAGE DE PROTEINE RESIDUELLE
Abstract: front page image
(EN)An automated method (Fig. 2) for evaluating the amount of residual protein levels following treatment of cellular specimens (fig. 2, 38). Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with $g(a)-naphthol butyrate with or without fluoride.
(FR)L'invention concerne un procédé automatisé (fig. 2) d'évaluation des taux de protéine résiduelle après traitement d'échantillons cellulaires (fig. 2, 38). Des procédés particuliers comportent une mesure de la phosphatase alcaline de neutrophiles de femme enceinte après traitement avec ou sans urée ou chaleur, une mesure de la phosphatase acide leucocytaire après traitement avec ou sans tartrate, et une mesure de l'estérase leucocytaire après traitement à l'$g(a)-naphtol butyrate avec ou sans fluorure.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)